Expert Opinion on Emerging Drugs
Latest Publications

TOTAL DOCUMENTS

807

(FIVE YEARS 94)

H-INDEX

43

(FIVE YEARS 5)

Published By Informa Uk (Taylor & Francis)

1744-7623, 1472-8214

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Emerging drugs for the treatment of myelofibrosis: phase II & III clinical trials

Expert Opinion on Emerging Drugs ◽

10.1080/14728214.2021.2015320 ◽

2021 ◽

Author(s):

Douglas Tremblay ◽

Ronald Hoffman

Keyword(s):

Clinical Trials ◽

Download Full-text

Emerging therapies for dry eye disease

Expert Opinion on Emerging Drugs ◽

10.1080/14728214.2021.2011858 ◽

2021 ◽

Author(s):

Lauren Mason ◽

Saad Jafri ◽

Isabelle Dortonne ◽

John D Sheppard

Keyword(s):

Dry Eye ◽

Dry Eye Disease ◽

Eye Disease ◽

Emerging Therapies

Download Full-text

An update on emerging drugs for the treatment of hypercholesterolemia

Expert Opinion on Emerging Drugs ◽

10.1080/14728214.2021.2009801 ◽

2021 ◽

Author(s):

Adam J Nelson ◽

Kristen Bubb ◽

Stephen J Nicholls

Download Full-text

Emerging drugs for the treatment of postsurgical pain

Expert Opinion on Emerging Drugs ◽

10.1080/14728214.2021.2009799 ◽

2021 ◽

pp. 1-14

Author(s):

Esra Kutlu Yalcin ◽

Jorge Araujo-Duran ◽

Alparslan Turan

Keyword(s):

Postsurgical Pain

Download Full-text

Emerging biological drugs for the treatment of gastro-oesophageal adenocarcinoma

Expert Opinion on Emerging Drugs ◽

10.1080/14728214.2021.2010705 ◽

2021 ◽

Author(s):

Maria Alsina ◽

Marc Diez ◽

Josep Tabernero

Keyword(s):

Oesophageal Adenocarcinoma ◽

Biological Drugs

Download Full-text

Emerging therapies for Achondroplasia: changing the rules of the game

Expert Opinion on Emerging Drugs ◽

10.1080/14728214.2021.2005577 ◽

2021 ◽

Author(s):

Smitha Kumble ◽

Ravi Savarirayan

Keyword(s):

Emerging Therapies ◽

Rules Of The Game

Download Full-text

Letter to the editor: “Actinic keratosis: where do we stand and where is the future going to take us?”

Expert Opinion on Emerging Drugs ◽

10.1080/14728214.2021.2004694 ◽

2021 ◽

Author(s):

Morgan A. Farr ◽

Tejas P. Joshi ◽

Daniel J. Lewis

Keyword(s):

Actinic Keratosis ◽

Letter To The Editor ◽

Download Full-text

Emerging drugs for hemophilia A: insights into phase II and III clinical trials

Expert Opinion on Emerging Drugs ◽

10.1080/14728214.2021.1988073 ◽

2021 ◽

Author(s):

Hande Kizilocak ◽

Guy Young

Keyword(s):

Clinical Trials ◽

Phase Ii ◽

Hemophilia A ◽

Phase Ii And Iii

Download Full-text

The future of antibody therapy in Chronic Lymphocytic Leukemia

Expert Opinion on Emerging Drugs ◽

10.1080/14728214.2021.1966414 ◽

2021 ◽

Author(s):

Jennifer L. Crombie ◽

Jennifer R. Brown

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Antibody Therapy ◽

Lymphocytic Leukemia ◽

Download Full-text

Emerging protein kinase inhibitors for the treatment of rheumatoid arthritis

Expert Opinion on Emerging Drugs ◽

10.1080/14728214.2021.1964472 ◽

2021 ◽

Author(s):

Penélope Esther Palominos ◽

Ilka Benedet Lineburger ◽

Ricardo Machado Xavier

Keyword(s):

Rheumatoid Arthritis ◽

Protein Kinase ◽

Kinase Inhibitors ◽

Protein Kinase Inhibitors

Download Full-text